StockGuru Blog: NextGen Bioscience (NXGB) – Biotechnology Company with World Class Management
NextGen Bioscience, Inc. is a drug target acquisition and development company focused on identifying, evaluating and acquiring pioneering innovative cancer research patents, and adding substantial value to those products to demonstrate ‘proof of principle’. The Company is focused on the discovery, development and commercialization of novel therapeutics to fight cancer, in prostate and breast cancer. “NextGen” leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical companies. All acquisition candidates are underpinned by patent applications or granted patents which confer protection in the major jurisdictions worldwide. NextGen’s business model…